Clinical trial NCT04469855: Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®
Official title: Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®. A Multi-centre, Open-label, Non-interventional Post-marketing Study to Investigate the Long-term Safety and Effectiveness of Ozempic® (Semaglutide) in Japanese Patients With Type 2 Diabetes Mellitus Under Normal Clinical Practice Condition
Study type: OBSERVATIONAL
Overall status: ENROLLING_BY_INVITATION
Conditions: Diabetes Mellitus, Type 2
Lead sponsor: Novo Nordisk A/S
Sponsor class: INDUSTRY
First posted: 2020-07-14
Enrollment: 3000
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Japanese people with type 2 diabetes being treated in normal clinical practice conditions

Brief summary: The purpose of this study is to assess the safety of long-term treatment with Ozempic® in patients with type 2 diabetes mellitus. People will get Ozempic® as prescribed by their doctor. People will be in this study about 3 years. People above the age of 18 will be asked to fill in the quality of life (QOL) questionnaire (the QOL questionnaire is for the assessment of the influence of diabetes treatment on people's life). There is a possibility that people's blood sample would be provided to Novo Nordisk from their doctors in case of severe allergic reaction that might be caused by Ozempic®.


Eligibility criteria: Inclusion Criteria:

* Signed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
* The decision to initiate treatment with commercially available Ozempic® has been made by the patient/Legally Acceptable Representative (LAR) and the treating physician before and independently from the decision to include the patient in this study.
* Patients with Diabetes Mellitus, Type 2 (T2DM) who the physician has decided to start treatment with Ozempic®.
* Male or female, no age limitation.

Exclusion Criteria:

* Previous participation in this study. Participation is defined as having given informed consent in this study.
* Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
* Patients who fall under contraindications to the label.
* Patients who are or have previously been treated with Ozempic®.
* Female who is pregnant, breast-feeding or intends to become pregnant.

Primary outcomes:
measure: Number of adverse events (AEs)
timeFrame: From baseline (day 0) to end of study (month 36)
Secondary outcomes:
measure: Number of serious adverse reactions (SARs)
timeFrame: From baseline (day 0) to end of study (month 36)
measure: Number of adverse reactions (ARs)
timeFrame: From baseline (day 0) to end of study (month 36)
measure: Number of serious adverse events (SAEs)
timeFrame: From baseline (day 0) to end of study (month 36)
measure: Change in glycosylated haemoglobin A1c (HbA1c)
timeFrame: From baseline (day 0) to end of study (month 36)
measure: Change in fasting plasma glucose (FPG)
timeFrame: From baseline (day 0) to end of study (month 36)
measure: Change in body weight
timeFrame: From baseline (day 0) to end of study (month 36)
measure: Change in patient-reported outcomes (PROs) using the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire - total score
timeFrame: From baseline (day 0) to visit 5 (month 12)
measure: Change in patient-reported outcomes (PROs) using the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire - burden of social activities and daily activities
timeFrame: From baseline (day 0) to visit 5 (month 12)
measure: Change in patient-reported outcomes (PROs) using the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire - anxiety and dissatisfaction with treatment
timeFrame: From baseline (day 0) to visit 5 (month 12)
measure: Change in patient-reported outcomes (PROs) using the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire - hypoglycaemia
timeFrame: From baseline (day 0) to visit 5 (month 12)
measure: Change in patient-reported outcomes (PROs) using the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire - satisfaction with treatment
timeFrame: From baseline (day 0) to visit 5 (month 12)
Other outcomes:
Locations:
city: Koriyama-shi
country: Japan
facility: Novo Nordisk Investigational Site
state: Fukushima, Japan
city: Kamakura-shi
country: Japan
facility: Novo Nordisk Investigational Site
state: Kanagawa, Japan
city: Kawasaki-shi
country: Japan
facility: Novo Nordisk Investigational Site
state: Kanagawa, Japan
city: Yamato-shi
country: Japan
facility: Novo Nordisk Investigational Site
state: Kanagawa
city: Kumamoto-shi
country: Japan
facility: Novo Nordisk Investigational Site
state: Kumamoto, Japan
city: Miyazaki-shi
country: Japan
facility: Novo Nordisk Investigational Site
state: Miyazaki, Japan
city: Oita-shi
country: Japan
facility: Novo Nordisk Investigational Site
state: Oita, Japan
city: Izumisano-shi
country: Japan
facility: Novo Nordisk Investigational Site
state: Osaka, Japan
city: Kawagoe-shi
country: Japan
facility: Novo Nordisk Investigational Site
state: Saitama, Japan
city: Minato-ku
country: Japan
facility: Novo Nordisk Investigational Site
state: Tokyo, Japan
city: Imizu-shi
country: Japan
facility: Novo Nordisk Investigational Site
state: Toyama, Japan
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Aichi
country: Japan
facility: Novo Nordisk Investigational Site
city: Akita
country: Japan
facility: Novo Nordisk Investigational Site
city: Akita
country: Japan
facility: Novo Nordisk Investigational Site
city: Akita
country: Japan
facility: Novo Nordisk Investigational Site
city: Aomori
country: Japan
facility: Novo Nordisk Investigational Site
city: Aomori
country: Japan
facility: Novo Nordisk Investigational Site
city: Arakawa-ku, Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Asahikawa-shi, Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba-shi, Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Chichibu-city
country: Japan
facility: Novo Nordisk Investigational Site
city: Chitose, Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Ehime
country: Japan
facility: Novo Nordisk Investigational Site
city: Ehime
country: Japan
facility: Novo Nordisk Investigational Site
city: Ehime
country: Japan
facility: Novo Nordisk Investigational Site
city: Ehime
country: Japan
facility: Novo Nordisk Investigational Site
city: Ehime
country: Japan
facility: Novo Nordisk Investigational Site
city: Ehime
country: Japan
facility: Novo Nordisk Investigational Site
city: Ehime
country: Japan
facility: Novo Nordisk Investigational Site
city: Ehime
country: Japan
facility: Novo Nordisk Investigational Site
city: Ehime
country: Japan
facility: Novo Nordisk Investigational Site
city: Ehime
country: Japan
facility: Novo Nordisk Investigational Site
city: Ehime
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukui-shi, Fukui
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukui
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka-shi, Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukushima-shi, Fukushima
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukushima
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukushima
country: Japan
facility: Novo Nordisk Investigational Site
city: Fukushima
country: Japan
facility: Novo Nordisk Investigational Site
city: Gifu-shi, Gifu
country: Japan
facility: Novo Nordisk Investigational Site
city: Gifu
country: Japan
facility: Novo Nordisk Investigational Site
city: Gifu
country: Japan
facility: Novo Nordisk Investigational Site
city: Gifu
country: Japan
facility: Novo Nordisk Investigational Site
city: Gifu
country: Japan
facility: Novo Nordisk Investigational Site
city: Gifu
country: Japan
facility: Novo Nordisk Investigational Site
city: Gifu
country: Japan
facility: Novo Nordisk Investigational Site
city: Gumma
country: Japan
facility: Novo Nordisk Investigational Site
city: Gumma
country: Japan
facility: Novo Nordisk Investigational Site
city: Gumma
country: Japan
facility: Novo Nordisk Investigational Site
city: Gumma
country: Japan
facility: Novo Nordisk Investigational Site
city: Gunma
country: Japan
facility: Novo Nordisk Investigational Site
city: Gunma
country: Japan
facility: Novo Nordisk Investigational Site
city: Gunma
country: Japan
facility: Novo Nordisk Investigational Site
city: Higashiosaka-shi, Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Hiroshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Hiroshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Hiroshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Hiroshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Hiroshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Hiroshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Hosu-gun, Ishikawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogogoken
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Ibaraki
country: Japan
facility: Novo Nordisk Investigational Site
city: Ibaraki
country: Japan
facility: Novo Nordisk Investigational Site
city: Ibaraki
country: Japan
facility: Novo Nordisk Investigational Site
city: Ibaraki
country: Japan
facility: Novo Nordisk Investigational Site
city: Ibaraki
country: Japan
facility: Novo Nordisk Investigational Site
city: Ibaraki
country: Japan
facility: Novo Nordisk Investigational Site
city: Ibaraki
country: Japan
facility: Novo Nordisk Investigational Site
city: Ibaraki
country: Japan
facility: Novo Nordisk Investigational Site
city: Iruma-shi, Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Ishikawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Ishikawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Iwate
country: Japan
facility: Novo Nordisk Investigational Site
city: Iwate
country: Japan
facility: Novo Nordisk Investigational Site
city: Iwate
country: Japan
facility: Novo Nordisk Investigational Site
city: Iwate
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagoshima-shi, Kagoshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagoshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagoshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagoshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagoshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagoshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagoshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Kagoshima
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Kisarazu-shi, Chiba
country: Japan
facility: Novo Nordisk Investigational Site
city: Kobe, Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Kochi
country: Japan
facility: Novo Nordisk Investigational Site
city: Koshigaya-shi,Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Kumamoto
country: Japan
facility: Novo Nordisk Investigational Site
city: Kumamoto
country: Japan
facility: Novo Nordisk Investigational Site
city: Kyoto
country: Japan
facility: Novo Nordisk Investigational Site
city: Kyoto
country: Japan
facility: Novo Nordisk Investigational Site
city: Kyoto
country: Japan
facility: Novo Nordisk Investigational Site
city: Kyoto
country: Japan
facility: Novo Nordisk Investigational Site
city: Kyoto
country: Japan
facility: Novo Nordisk Investigational Site
city: Kyoto
country: Japan
facility: Novo Nordisk Investigational Site
city: Kyoto
country: Japan
facility: Novo Nordisk Investigational Site
city: Kyoto
country: Japan
facility: Novo Nordisk Investigational Site
city: Mie
country: Japan
facility: Novo Nordisk Investigational Site
city: Mie
country: Japan
facility: Novo Nordisk Investigational Site
city: Mie
country: Japan
facility: Novo Nordisk Investigational Site
city: Mie
country: Japan
facility: Novo Nordisk Investigational Site
city: Mitaka-shi, Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Miura-shi, Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Miyagi
country: Japan
facility: Novo Nordisk Investigational Site
city: Miyagi
country: Japan
facility: Novo Nordisk Investigational Site
city: Miyagi
country: Japan
facility: Novo Nordisk Investigational Site
city: Miyagi
country: Japan
facility: Novo Nordisk Investigational Site
city: Miyazaki
country: Japan
facility: Novo Nordisk Investigational Site
city: Miyazaki
country: Japan
facility: Novo Nordisk Investigational Site
city: Miyazaki
country: Japan
facility: Novo Nordisk Investigational Site
city: Miyazaki
country: Japan
facility: Novo Nordisk Investigational Site
city: Muroran-shi, Hokkaido
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagano
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagano
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagano
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagano
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagano
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagano
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagasaki
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagasaki
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagasaki
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagasaki
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagasaki
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagasaki
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagasaki
country: Japan
facility: Novo Nordisk Investigational Site
city: Nagasaki
country: Japan
facility: Novo Nordisk Investigational Site
city: Nara
country: Japan
facility: Novo Nordisk Investigational Site
city: Nara
country: Japan
facility: Novo Nordisk Investigational Site
city: Nara
country: Japan
facility: Novo Nordisk Investigational Site
city: Nara
country: Japan
facility: Novo Nordisk Investigational Site
city: Nara
country: Japan
facility: Novo Nordisk Investigational Site
city: Nara
country: Japan
facility: Novo Nordisk Investigational Site
city: Nara
country: Japan
facility: Novo Nordisk Investigational Site
city: Nara
country: Japan
facility: Novo Nordisk Investigational Site
city: Nara
country: Japan
facility: Novo Nordisk Investigational Site
city: Niigata-shi, Niigata
country: Japan
facility: Novo Nordisk Investigational Site
city: Niigata
country: Japan
facility: Novo Nordisk Investigational Site
city: Niigata
country: Japan
facility: Novo Nordisk Investigational Site
city: Niigata
country: Japan
facility: Novo Nordisk Investigational Site
city: Niigata
country: Japan
facility: Novo Nordisk Investigational Site
city: Nishinomiya-shi, Hyogo
country: Japan
facility: Novo Nordisk Investigational Site
city: Oita
country: Japan
facility: Novo Nordisk Investigational Site
city: Oita
country: Japan
facility: Novo Nordisk Investigational Site
city: Oita
country: Japan
facility: Novo Nordisk Investigational Site
city: Oita
country: Japan
facility: Novo Nordisk Investigational Site
city: Oita
country: Japan
facility: Novo Nordisk Investigational Site
city: Okayama-shi, Okayama
country: Japan
facility: Novo Nordisk Investigational Site
city: Okayama
country: Japan
facility: Novo Nordisk Investigational Site
city: Okayama
country: Japan
facility: Novo Nordisk Investigational Site
city: Okayama
country: Japan
facility: Novo Nordisk Investigational Site
city: Okayama
country: Japan
facility: Novo Nordisk Investigational Site
city: Okayama
country: Japan
facility: Novo Nordisk Investigational Site
city: Okinawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Okinawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Okinawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Okinawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Okinawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka-shi, Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka-shi, Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka-shi, Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Osaki-shi, Miyagi
country: Japan
facility: Novo Nordisk Investigational Site
city: Ota-ku, Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Ota-ku, Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Saga
country: Japan
facility: Novo Nordisk Investigational Site
city: Saga
country: Japan
facility: Novo Nordisk Investigational Site
city: Saga
country: Japan
facility: Novo Nordisk Investigational Site
city: Saga
country: Japan
facility: Novo Nordisk Investigational Site
city: Saga
country: Japan
facility: Novo Nordisk Investigational Site
city: Saga
country: Japan
facility: Novo Nordisk Investigational Site
city: Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Sendai-shi, Miyagi
country: Japan
facility: Novo Nordisk Investigational Site
city: Shiga
country: Japan
facility: Novo Nordisk Investigational Site
city: Shiga
country: Japan
facility: Novo Nordisk Investigational Site
city: Shiga
country: Japan
facility: Novo Nordisk Investigational Site
city: Shiga
country: Japan
facility: Novo Nordisk Investigational Site
city: Shimane
country: Japan
facility: Novo Nordisk Investigational Site
city: Shimane
country: Japan
facility: Novo Nordisk Investigational Site
city: Shimane
country: Japan
facility: Novo Nordisk Investigational Site
city: Shimotsuga-gun, Tochigi
country: Japan
facility: Novo Nordisk Investigational Site
city: Shimotsuke-shi, Tochigi
country: Japan
facility: Novo Nordisk Investigational Site
city: Shinjuku-ku, Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Shinjyuku-ku Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Shizuoka-city, Shizuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Shizuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Shizuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Shizuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Shizuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Shizuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Shizuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Shizuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Shizuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Soka-shi, Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Suzaka-shi ,Nagano
country: Japan
facility: Novo Nordisk Investigational Site
city: Tamana-shi, Kumamoto
country: Japan
facility: Novo Nordisk Investigational Site
city: Tochigi
country: Japan
facility: Novo Nordisk Investigational Site
city: Tochigi
country: Japan
facility: Novo Nordisk Investigational Site
city: Tochigi
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokorozawa-shi,Saitama
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokushima
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokushima
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokushima
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tokyo
country: Japan
facility: Novo Nordisk Investigational Site
city: Tomigusuku-shi, Okinawa
country: Japan
facility: Novo Nordisk Investigational Site
city: Tottori
country: Japan
facility: Novo Nordisk Investigational Site
city: Tottori
country: Japan
facility: Novo Nordisk Investigational Site
city: Toyama-shi, Toyama
country: Japan
facility: Novo Nordisk Investigational Site
city: Toyama
country: Japan
facility: Novo Nordisk Investigational Site
city: Toyonaka-shi, Osaka
country: Japan
facility: Novo Nordisk Investigational Site
city: Wakayama
country: Japan
facility: Novo Nordisk Investigational Site
city: Yamagata
country: Japan
facility: Novo Nordisk Investigational Site
city: Yamagata
country: Japan
facility: Novo Nordisk Investigational Site
city: Yamaguchi
country: Japan
facility: Novo Nordisk Investigational Site
city: Yamaguchi
country: Japan
facility: Novo Nordisk Investigational Site
city: Yamaguchi
country: Japan
facility: Novo Nordisk Investigational Site
city: Yamanashi
country: Japan
facility: Novo Nordisk Investigational Site
city: Yanagawa-shi, Fukuoka
country: Japan
facility: Novo Nordisk Investigational Site
city: Yokohama, Kanagawa
country: Japan
facility: Novo Nordisk Investigational Site
Study officials:
affiliation: Novo Nordisk A/S
name: Clinical Reporting Anchor and Disclosure (1452)
role: STUDY_DIRECTOR
References: